Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/20—Pills, tablets, discs, rods
  • A61K9/2004—Excipients; Inactive ingredients
  • A61K9/2022—Organic macromolecular compounds
  • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
  • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/10—Dispersions; Emulsions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/0012—Galenical forms characterised by the site of application
  • A61K9/0048—Eye, e.g. artificial tears
  • A61K9/0051—Ocular inserts or implants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
  • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
  • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
  • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
  • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P27/00—Drugs for disorders of the senses
  • A61P27/02—Ophthalmic agents

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• Pharmacology & Pharmacy (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Animal Behavior & Ethology (AREA)
• Epidemiology (AREA)
• Ophthalmology & Optometry (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Inorganic Chemistry (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Organic Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Dispersion Chemistry (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicinal Preparation (AREA)
• Materials For Medical Uses (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=52001114

Family Applications (1)

Country Status (24)

Families Citing this family (9)

Family Cites Families (9)

• 2014
  • 2014-11-14 DK DK14805768.0T patent/DK3068403T3/da active
  • 2014-11-14 PL PL14805768T patent/PL3068403T3/pl unknown
  • 2014-11-14 NZ NZ719953A patent/NZ719953A/en not_active IP Right Cessation
  • 2014-11-14 HU HUE14805768A patent/HUE050913T2/hu unknown
  • 2014-11-14 SG SG10201809363SA patent/SG10201809363SA/en unknown
  • 2014-11-14 CN CN201480062403.7A patent/CN105764517A/zh active Pending
  • 2014-11-14 WO PCT/US2014/065804 patent/WO2015073895A1/en not_active Ceased
  • 2014-11-14 CA CA2929689A patent/CA2929689A1/en active Pending
  • 2014-11-14 MY MYPI2016000899A patent/MY176039A/en unknown
  • 2014-11-14 US US14/542,189 patent/US20150140062A1/en not_active Abandoned
  • 2014-11-14 SI SI201431652T patent/SI3068403T1/sl unknown
  • 2014-11-14 KR KR1020167015466A patent/KR102475746B1/ko active Active
  • 2014-11-14 PT PT148057680T patent/PT3068403T/pt unknown
  • 2014-11-14 KR KR1020247013455A patent/KR20240058976A/ko not_active Ceased
  • 2014-11-14 EP EP14805768.0A patent/EP3068403B2/en active Active
  • 2014-11-14 EP EP20173457.1A patent/EP3714875A1/en active Pending
  • 2014-11-14 KR KR1020227018854A patent/KR20220082934A/ko not_active Ceased
  • 2014-11-14 MX MX2016006334A patent/MX2016006334A/es unknown
  • 2014-11-14 AU AU2014348369A patent/AU2014348369B2/en active Active
  • 2014-11-14 UA UAA201605224A patent/UA122117C2/uk unknown
  • 2014-11-14 RU RU2016119132A patent/RU2690841C1/ru active
  • 2014-11-14 ES ES14805768T patent/ES2819215T5/es active Active
  • 2014-11-14 JP JP2016530991A patent/JP6675307B2/ja active Active
• 2016
  • 2016-05-09 IL IL245548A patent/IL245548A0/en unknown
  • 2016-05-11 PH PH12016500869A patent/PH12016500869B1/en unknown
  • 2016-05-13 CL CL2016001167A patent/CL2016001167A1/es unknown
  • 2016-05-13 MX MX2022002306A patent/MX2022002306A/es unknown
• 2019
  • 2019-12-13 JP JP2019225503A patent/JP7022735B2/ja active Active
• 2020
  • 2020-06-30 AU AU2020204362A patent/AU2020204362A1/en not_active Abandoned
  • 2020-09-14 CY CY20201100867T patent/CY1123344T1/el unknown
• 2022
  • 2022-02-23 IL IL290837A patent/IL290837A/en unknown
  • 2022-06-29 AU AU2022204607A patent/AU2022204607A1/en not_active Abandoned
• 2024
  • 2024-08-09 AU AU2024205640A patent/AU2024205640B2/en active Active
• 2025
  • 2025-02-21 US US19/060,301 patent/US20250319031A1/en active Pending

Also Published As

Similar Documents